PCS
RDY icon

Personal CFO Solutions’s Dr. Reddy's Laboratories RDY Stock Holding History

Personal CFO Solutions’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,805
Closed -$311K – 444
2020
Q4 		$311K Buy
21,805
+855
+4% +$11.5K 0.08% 236
2020
Q3 		$0 Buy
20,950
+530
+3% +$6.32K ﹤0.01% 294
2020
Q2 		$217K Buy
+20,420
New +$208K 0.06% 271

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Personal CFO Solutions's RDY Position: Q1 2021 in Review

Personal CFO Solutions sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 21,805 shares — an estimated $311K sold.

Personal CFO Solutions first reported a position in RDY in Q2 2020 and held it in 3 quarters. The position peaked at $311K in Q4 2020. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

  • Personal CFO Solutions reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
  • Personal CFO Solutions sold 21,805 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $311K.
  • Personal CFO Solutions first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 3 quarters.
  • Personal CFO Solutions's Dr. Reddy's Laboratories position peaked at $311K in Q4 2020.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Personal CFO Solutions's 13F filing for Q1 2021, filed 21 Apr 2021.